Abstract
Effects of the hormones of the hypothalamic-pituitary-thyroid axis on some basic parameters of the activity of protein C anticoagulation pathway in rats are studied. Thyrotropin-releasing hormone (0.06 mg/kg body mass), thyrotropin (1 IU/kg), triiodothyronine (T3) (0.08 mg/kg), thyroxine (T4) (0.08 mg/kg), administered subcutaneously for three consecutive days on four different groups of rats increased significantly activated protein C, free protein S and protein S activity, and reduced the soluble endothelial protein C receptor. Protein C antigen and total protein S were significantly elevated only by thyrotropin-releasing hormone and thyroid-stimulating hormone, but they were not affected by T3 and T4 treatment. The data indicate the hypothalamic-pituitary-thyroid axis is involved in the regulation of the protein C anticoagulation pathway in rats by activation of this system, suggesting a tendency of hypocoagulability.
Similar content being viewed by others
Abbreviations
- TRH:
-
Thyrotropin releasing hormone
- TSH:
-
Thyrotropin (thyroid-stimulating hormone)
- T3:
-
Trijodthyronin
- T4:
-
Thyroxine
- EPCR:
-
endothelial protein C receptor
- sEPCR:
-
soluble form of endothelial protein C receptor
- PC:
-
protein C
- aPC:
-
activated protein C
References
Castellino F.J., Ploplis V.A., The protein C pathway and pathologic processes, J. Thromb. Haemost., 2009, 7, 140–145
Dahlback B., Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases, J. Int. Med., 2005, 257, 209–223
Tanaka K., Nigel S.K., Jerrold H.L., Blood Coagulation: Hemostasis and Thrombin Regulation, Anesth. Analg., 2009, 108, 1433–1446
Joyce D.E., Gelbert L., Ciaccia A., DeHoff B., Grinnell B.W., Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis, J. Biol. Chem., 2001, 276, 11199–11203
Minami T., Sugiyama A., Wu S.Q., Abid R., Kodama T., Aird W.C., Thrombin and phenotypic modulation of the endothelium, Arterioscler. Thromb. Vasc. Biol., 2004, 24, 41–53
Erem C., Ersoz H.O., Karti S.S., Ukinc K., Hacihasanoglu A., Deger O., et al., Blood coagulation and fibrinolysis in patients with hyperthyroidism, J. Endocrinol. Invest., 2002, 25, 345–350
Canturk Z., Cetinarslan B., Tarkun I., Canturk N.Z., Ozden M., Duman C., Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism, Thyroid, 2003, 13, 971–977
Gullu S., Sav H., Kamel N., Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism, Eur. J. Endocrinol., 2005, 152, 355–361
Franchini M., Hemostatic changes in thyroid diseases, Haemost. Thromb., Hematol., 2006, 11, 203–208
Debeij J, Cannegieter S., Van Zaane B., Smit J., Corssmit E., Rosendaal F., et al., The effect of changes in thyroxine and thyroid-stimulating hormone levels on the coagulation system, J. Thromb. Haemost., 2010, 8, 2823–2826
Zhang W., Tian L., Han Y., Ma H., Wang L., Guo J., et al., Presence of thyrotropin receptor in hepatocytes: not a case of illegitimate transcription, J. Cell. Mol. Med., 2009, 13, 4636–4642
Yen P., Physiological and molecular basis of thyroid hormone action, Physiol. Rev., 2001, 81, 1097–1142
Lifschitz B., Defesi C., Surks M., Thyrotropin response to thyrotropin-releasing hormone in the euthyroid rat: Dose-response, time course, and demonstration of partial refractoriness to a second dose of thyrotropin-releasing hormone, Endocrinology, 1978, 102, 1775–1782
Huff M., Culm-Merdek K., Fogle R., Gotschall R., Sampath K., Sendak R., et al., Pharmacokinetics and pharmacodynamics following low dose TSH administration in aged ovariectomized rats, FASEB J., 2007, 21, 5711–5713
Greeley G., Lipton M., Kizer J., Serum Thyroxine, Triiodothyronine, and TSH levels and TSH Release after TRH in aging male and female rats, Endocr. Res. Commun., 1982–1983, 9, 169–177
Negrev N.N., Radev R.Z., Velikova M.S., Anogeianaki A., Screening study of the effects of the hypothalamic-pituitary-thyroid axis on hemostasis in rats, J. Biol. Regul. Homeostat. Agent., 2006, 20, 53–57
España F., Vagà A., Mira Y., Medina P., Estellés A., Villa P., et al., Low level of circulating activated protein C is a risk factor for venous thromboembolism, Thromb. Haemost., 2001, 86, 1368–1373
Drury, R.A.B., Wallington E.A., Carleton’s histological technique, 5th Ed., Oxford University Press, Oxford, UK, 1980
Esmon C.T., The protein C pathway, Chest, 2003, 124, 26S–32S
Van de Wouwer M., Collen D., Conway E.M., Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation, Arterioscler. Thromb. Vasc. Biol., 2004, 24, 1374–1383
Liaw P.C.Y, Neuenschwander P.F., Smirnov M.D., Esmon C.T., Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function, J. Biol. Chem., 2000, 275, 5447–5452
Castoldi E., Hackeng T.M., Regulation of coagulation by protein S, Curr. Opin. Hematol., 2008, 15, 529–536
Rosing J., Maurissen L.F.A., Tchaikovski S.N., Tans G., Hackeng T.M., Protein S is a cofactor for tissue factor pathway inhibitor, Thromb. Res., 2008, 122, S60–S63
Negrev N.N., Radev R.Z., Velikova M.S., Anogeianaki A., Effects of the hormones of the thyroid axis on the vitamin K-dependent plasma factors of blood coagulation (II, VII, IX and X), Int. J. Immunopathol. Pharmacol., 2008, 21, 221–226
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Negrev, N., Nyagolov, Y., Stefanova, M. et al. Thyroid hormonal axis regulates protein C anticoagulation pathway in rats. cent.eur.j.biol. 6, 518–523 (2011). https://doi.org/10.2478/s11535-011-0031-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11535-011-0031-y